The National Board of Examinations in Medical Sciences (NBEMS) has announced the results of the Foreign Medical Graduate ...

Q. Two members of our book group have early signs of cognitive impairment. We have become so close after 10 years of being ...

We all forget things now and then—people’s names, where you put your car keys, that dentist appointment that was scheduled ...

For further information, please contact: Oskar Bosson, VP Communications and IR E-mail ... and several other markets for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...

This is the 29 th published study on the use of BrainHQ in patients with MCI or other forms of pre-dementia. Prior studies ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...

Reeves for support in securing funding for the project, as well as Mississippi Gulf Coast Community College for partnering to ...

PITTSFIELD -- MCI defeated Belfast by a score of 57-54 on Thursday night. Belfast had possession with 20 seconds left looking ...

According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...

Mild cognitive impairment (MCI) refers to a noticeable decline in cognitive abilities, such as memory and thinking, that is more severe than expected for a person's age but not severe enough to ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...